Puget Technologies Has An Interesting Business Model
Puget Technologies, Inc. (OTC: PUGE) is a development-stage company. The Company is engaged in developing and marketing of consumer-oriented products ready for commercialization. The Company’s subsidiaries include B-29 Energy, Inc. (B-29), which is in the development stage. B-29 is engaged in the business of development and distribution of energy products.
B-29’s products include B-29 Energy Drink and various medical marijuana products, which are under development. B-29 produces these products through its subsidiary, Cannabis Biotech. The Company is also engaged in the development of three dimensional (3D) printing and supporting technologies for My3DP personal printer. The applications of the Company’s products are in various sectors, which include crafting, jewelry and domestic goods.
PUGE recently announces the formation of Cannabis BioTech, through which it is entering the growing medical marijuana industry. Cannabis BioTech is poised to become an emerging front-runner in the cutting-edge field of cannabinoid science.
Cannabis BioTech is in the research and development stages of creating a cannabis (marijuana) derived medicinal product line. These products are intended to deliver the benefits of marijuana without the need to smoke or inhale it.
President and CEO of PUGE Ron Leyland said, “We are pleased to complete the establishment of Cannabis BioTech. We are confident our new subsidiary will fill a void in this rapidly increasing market among many medical marijuana license holders who have no desire to ‘smoke pot.’” He added, “Patients will feel comfortable using our products because great care will be taken to determine proper dosages and protocols, ensuring strict quality standards.”
According to The Wall Street Street Journal MarketWatch, many analysts expect the $1.7 billion U.S. medical marijuana market to quadruple in size during the next five years.